Bradley Herring insider trades: Enfusion (ENFN) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Bradley reports to the SEC
Open-market buys and sales
7 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Mar 5, 2025 | ENFN | ↓ Sell | 4,645 | $11.38 | $53K | Direct | Mar 7, 2025 (2d) |
| Mar 3, 2025 | ENFN | ↓ Sell | 1,533 | $11.48 | $18K | Direct | Mar 5, 2025 (2d) |
| Jan 7, 2025 | ENFN | ↓ Sell | 4,134 | $10.13 | $42K | Direct | Jan 10, 2025 (3d) |
| Dec 20, 2024 | ENFN | ↓ Sell | 24,443 | $10.61 | $259K | Direct | Dec 26, 2024 (6d) |
| Jan 9, 2024 | ENFN | ↓ Sell | 4,088 | $9.09 | $37K | Direct | Jan 10, 2024 (1d) |
| Aug 9, 2021 | FOUR | ↓ Sell | 2,000 | $89.30 | $179K | Direct | Aug 11, 2021 (2d) |
| Jun 10, 2021 | FOUR | ↓ Sell | 5,940 | $93.16 | $553K | Direct | Jun 14, 2021 (4d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Bradley Herring's insider trades
Bradley Herring is Chief Financial Officer at Enfusion (ENFN). Since Jun 10, 2021, Bradley has reported no open-market purchases and 7 sales worth $1.1M on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include grants and awards (11 filings), shares withheld for taxes (7 filings), option exercises (1 filing), shares returned to the company (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every ENFN insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.